Año 2024 / Volumen 116 / Número 2
Editorial
Liver transplantation in colorectal metastases. Is there an indication for this procedure?

59-62

DOI: 10.17235/reed.2023.9873/2023

Javier A. Cienfuegos, Gabriel Zozaya, Fernando Rotellar,

Resumen
Almost 25 % of patients with colorectal cancer present metastases at the time of diagnosis and 50 % go on to develop metastases in the course of the disease. Surgical resection is the only curative treatment although only between 20 % and 30 % of patients present resectable lesions. Although liver transplantation is contraindicated in unresectable metastases of colorectal cancer, ever since the publication of the results of a pilot study there has been renewed interest in transplantation in these patients. In two consecutive trials overall and recurrence-free 5-year survival rates of 83 % and 35 % respectively, have been reported, Currently several trials are ongoing which are expected to allow the patient selection criteria for the indication of liver transplantation to be refined.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Siegel RL, Wagle NS, Cercek A, et al.. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 2023;73:233-254
2. Hernandez Dominguez O, Yilmaz S, Steele SR. Stage IV Colorectal Cancer Management and Treatment. J. Clin Med 2023;12. Available at: http://www.ncbi.nlm.nih.gov/pubmed/36902858.
3. Tsilimigras DI, Brodt P, Clavien PA, et al. Liver metastases. Nat Rev Dis Prim. 2021;7:27
4. Kattan MW, Gönen M, Jarnagin WR, et al. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008;247:282–287.
5. Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up . Ann Oncol 2023;34:10–32.
6. Ros J, Salva F, Dopazo C, et al. Liver transplantation in metastatic colorectal cancer: are we ready for it? Br J. Canc. 2023;128:1797–1806. Available at: http://www.ncbi.nlm.nih.gov/pubmed/36879000.
7. Mühlbacher F, Huk I, Steininger R, et al. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? Tranplant Proc 1991:1567–8.
8. Hagness M, Foss A, Line PD, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 2013;257:800–806.
9. Hagness M, Foss A, Egge TS, et al.. Patterns of recurrence after liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg Oncol. 2014;21:1323–1329.
10. Solheim JM, Dueland S, Line PD HM. Transplantation for Nonresectable Colorectal Liver Metastases - Long Term follow- up of the First Prospective Pilot Study. Ann Surg 2022 doi: 101097/SLA0000000000005703 Online ahead of print.
11. Maspero M, Sposito C, Virdis M, et al. Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues. Cancers 2023;15. Available at: http://www.ncbi.nlm.nih.gov/pubmed/36672295.
12. Paradis C. Bias in surgical research. Ann Surg 2008;248:180–188.
13. Toso C, Pinto Marques H, Andres A, et al. Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved. Liver Transplant 2017;23:1073–1076.
14. Dueland S, Syversveen T, Solheim JM, et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg 2020;271:212–218.
15. Lanari J, Hagness M, Sartori A, et al. Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score. Transpl Int 2021;34:1722–1732.
16. Hernandez-Alejandro R, Ruffolo LI, Sasaki K, et al. Recipient and Donor Outcomes after Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases. JAMA Surg 2022;157:524–530.
17. Rajendran L, Claasen M P, McGilvray I D, et al.. Toronto Management of Initially Unresectable Liver Metastases from Colorectal Cancer in a Living Donor Liver Transplant Program. J Am Coll Surg. PMID: 37130158, DOI: 10.1097/XCS.0000000000000734 Online ahead of print
18. Bonney GK, Chew CA, Lodge P, et al. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol. 2021;6:933–946.
19. Mazzaferro V, Sposito C, Zhou J, et al. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology 2018;154:128–139.
20. Schiano TD, Bourgoise T, Rhodes R. High-risk liver transplant candidates: An ethical proposal on where to draw the line. Liver Transpl. 2015;21:607–611.
21. León RR, Rodríguez ES, Ortega AM, et al. Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study. Rev Esp Enferm Dig 2022;114:219–225.
22. Hainsworth JD, Meric-Bernstam F, Swanton C, et al. Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIA multiple basket study. J Clin Oncol 2018;36:536–542.
23. Cercek A, Lumish M, Sinopoli J, et al. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer. N Engl J Med 2022;386:2363–2376.
24. Königsrainer A, Templin S, Capobianco I, et al. Paradigm Shift in the Management of Irresectable Colorectal Liver Metastases: Living Donor Auxiliary Partial Orthotopic Liver Transplantation in Combination with Two-stage Hepatectomy (LD-RAPID). Ann Surg 2019;270:327–332.
25. Line PD, Ruffolo LI, Toso C,et al. Liver transplantation for colorectal liver metastases: What do we need to know? Int J Surg 2020;82:87–92.
Artículos relacionados

Imagen en Patología Digestiva

Síndrome de encefalopatía posterior reversible (PRES) en el postrasplante hepático

DOI: 10.17235/reed.2022.8694/2022

Carta

Neurotoxicidad por ertapenem

DOI: 10.17235/reed.2021.8469/2021

Revisión

La fragilidad física en el contexto del trasplante hepático

DOI: 10.17235/reed.2020.7448/2020

Carta

Manejo de los aneurismas de la arteria hepática

DOI: 10.17235/reed.2020.7219/2020

Imagen en Patología Digestiva

Hemangioendotelioma epitelioide como causa infrecuente de tumor hepático

DOI: 10.17235/reed.2020.7127/2020

Carta al Editor

Post-transplant lymphoproliferative disease after liver transplantation

DOI: 10.17235/reed.2017.5387/2017

Original

Síndrome linfoproliferativo en el trasplante hepático

DOI: 10.17235/reed.2017.4228/2016

Instrucciones para citar
Cienfuegos J, Zozaya G, Rotellar F. Liver transplantation in colorectal metastases. Is there an indication for this procedure?. 9873/2023


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 793 veces.
Este artículo ha sido descargado 183 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 27/07/2023

Aceptado: 31/07/2023

Prepublicado: 04/08/2023

Publicado: 07/02/2024

Tiempo de prepublicación: 8 días

Tiempo de edición del artículo: 195 días


Compartir
Este artículo aun no tiene valoraciones.
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas